Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows From Operating Activities:
Net loss	$ (1,275,406)	$ (1,691,567)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of derivative liabilities	(5,800)
Non-cash interest expense - warrants	(74,315)	(46,131)
Stock-based compensation:
Stock-based compensation		328,905
Changes in operating assets and liabilities:
Prepaid expenses	80,377	79,338
Other current assets	10,025	8,434
Accounts payable	415,350	506,867
Accrued compensation	58,870	27,862
Net Cash Used In Operating Activities	(173,852)	(309,613)
Cash Flows From Financing Activities:
Proceeds from issuance of Series B Convertible Preferred Stock and warrants	25,000
Repayment of financing liability	(20,000)
Net Cash Provided By Financing Activities	151,672	219,960
Net Decrease In Cash	(22,180)	(89,653)
Cash - Beginning of Period	22,203	222,665
Cash - End of Period	23	133,012
Supplemental Disclosures of Cash Flow Information:
Interest
Income taxes		945
Non-cash investing and financing activities:
Issuance of warrants in connection with the issuance of notes payable		21,202
Accrual of warrant obligations in connection with issuance of convertible notes payable	6,666	40,167
Common stock issued in satisfaction of accrued compensation	(45,000)
Conversion of accrued expenses into note principal		413,018
Accrual of earned preferred stock dividends	(326,665)	(297,517)
Conversion of convertible notes payable and accrued interest into Series C Preferred Stock and common stock	104,910	52,060
Issuance of warrants in connection with issuance of Series B Preferred Stock	3,200
Issuance of embedded derivative liabilities in connection with issuance of Series B Preferred Stock	1,900
Common Stock [Member]
Stock-based compensation:
Stock-based compensation	262,351	330,000
Warrant [Member]
Stock-based compensation:
Stock-based compensation	26,544	(1,095)
Nonrelated Party [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount	4,954	35,721
Changes in operating assets and liabilities:
Accrued expenses	96,273	139,948
Accrued interest	32,738	77,252
Cash Flows From Financing Activities:
Proceeds from issuance of convertible notes payable		219,960
Related Party [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount	1,002	104,527
Changes in operating assets and liabilities:
Accrued expenses	14,500	14,500
Accrued interest	178,685	104,731
Cash Flows From Financing Activities:
Proceeds from issuance of convertible notes payable	$ 146,672

Cell Source, Inc. 10-Q